4 vs 7 Points Blood Glucose Monitoring in Gestational Diabetes on Dietary Modification
4 Versus 7 Points Self-monitoring Blood Glucose in Gestational Diabetes on Diet Modification-A Randomised Control Trial
1 other identifier
interventional
200
1 country
2
Brief Summary
This study aims to compare between 4 and 7 points blood glucose monitoring in women with gestational diabetes on diet modification.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2019
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 17, 2019
CompletedFirst Posted
Study publicly available on registry
September 24, 2019
CompletedStudy Start
First participant enrolled
October 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedNovember 9, 2023
November 1, 2023
2.7 years
September 17, 2019
November 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (25)
Pregnancy outcome of participants
Mean gestational age at delivery in weeks
From date of randomisation up to 40 weeks gestation
Pregnancy outcome of participants
Rate of spontaneous or induced labour in percentage
From date of randomisation up to 40 weeks gestation and participants are diagnosed in established labour
Pregnancy outcome of participants
Rate of vaginal, instrumental or caesarean delivery in percentage
From date of randomisation up to 40 weeks gestation when the participants had given birth to the newborn
Pregnancy outcome of participants
Rate of intrapartum complications such as postpartum haemorrhage, shoulder dystocia and third or fourth degree tear in percentage
From date of randomisation up to 40 weeks gestation during progress of labour up to 24 hours post delivery
Pregnancy outcome of participants
Mean neonatal birth weight in kilogram
At the point of birth of the neonate
Pregnancy outcome of participants
Rate of neonates born with Apgar score at five minutes of less than 7 in percentage
At the point of birth of the neonate
Pregnancy outcome of participants
Rate of neonatal intensive care unit admission in percentage
At the point of birth of the neonate
Pregnancy outcome of participants
Rate of neonatal complications such as intrauterine fetal demise, neonatal death, neonatal hypoglycaemia, neonatal jaundice, neonatal respiratory distress syndrome and neonatal sepsis in percentage
From date of randomisation up to 7 days after birth of the neonate
Demographic data of participants
Mean age of participants in years
On the date of randomisation
Demographic data of participants
Rate of each different races such as Malay, Chinese and Indian in percentage
On the date of randomisation
Demographic data of participants
Rate of parity such as nulliparous or multiparous in percentage
On the date of randomisation
Demographic data of participants
Mean prepregnancy body mass index in kg/m\^2
On the date of randomisation up to 40 weeks gestation based on the first trimester weight documented in the antenatal record
Demographic data of participants
Mean total weight gain in kilogram
On the date of randomisation till 40 weeks gestation
Demographic data of participants
Rate of positive family history of diabetes mellitus in percentage
On the date of randomisation up to 40 weeks gestation
Demographic data of participants
Rate of previous pregnancy affected by gestational diabetes mellitus in percentage
On the date of randomisation up to 40 weeks gestation
Demographic data of participants
Rate of previous pregnancy complicated by fetal macrosomia in percentage
On the date of randomisation up to 40 weeks gestation
Clinical characteristics of participants
Mean gestational age gestational diabetes mellitus is diagnosed in weeks
On the date of randomisation up to 40 weeks gestation
Clinical characteristics of participants
Mean fasting glucose level from the modified glucose tolerance test in mmol/l
On the date of randomisation up to 40 weeks gestation
Clinical characteristics of participants
Mean two hours post 75 gram glucose load from the modified glucose tolerance test in mmol/l
On the date of randomisation up to 40 weeks gestation
Clinical characteristics of participants
Rate of antenatal complications such as preeclampsia, threatened preterm labour, preterm prelabour rupture of membranes, anaemia,
At the point of randomisation till 40 weeks gestation
Clinical characteristics of participants
Mean level of glycosylated haemoglobin in percentage
At the point of randomisation till 40 weeks gestation
Clinical characteristics of participants
Mean level of serum fructosamine in percentage
At the point of randomisation till 40 weeks gestation
Clinical characteristics of participants
Mean level of fasting blood glucose in self monitoring blood glucose in mmol/l
At the point of randomisation till 40 weeks gestation
Clinical characteristics of participants
Mean level of pre-meal blood glucose in self monitoring blood glucose in mmol/l
At the point of randomisation till 40 weeks gestation
Clinical characteristics of participants
Mean level of one hour post-meal blood glucose in self monitoring blood glucose in mmol/l
At the point of randomisation till 40 weeks gestation
Secondary Outcomes (4)
Requirement of treatment in participants
From the date of randomisation up to 40 weeks gestation
Requirement of treatment in participants
From point of randomisation till 40 weeks gestation
Participants' compliance
From point of randomisation till 40 weeks gestation
Participants' satisfaction
From point of randomisation till 40 weeks gestation
Study Arms (2)
4 points blood glucose monitoring
OTHER4 points of self monitoring blood glucose which comprises of fasting, 1 hour post breakfast, 1 hour post lunch and 1 hour post dinner
7 points blood glucose monitoring
OTHER7 points of self monitoring blood glucose which comprises of fasting,1 hour post breakfast, 1 hour pre and post lunch, 1 hour pre and post dinner, pre bed at 10 pm
Interventions
Patients with gestational diabetes will be seen by the dietitian to be taught diet modification
Eligibility Criteria
You may qualify if:
- Aged 18-45 years old
- Pregnant women with gestational diabetes mellitus on diet modification
- Confirmed gestational diabetes mellitus using National Institute for Health and Care Excellence guideline by 75g oral glucose tolerance test after 14 weeks
- Gestational age at recruitment 20-34 week
You may not qualify if:
- bad obstetrics history.
- Women with underlying medical disorders such as hypertension, autoimmune diseases on steroids
- fetal anomaly.
- Women planning to deliver in other centres
- Women who refuse to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Antenatal clinic, UKM Medical Centre
Cheras, Kuala Lumpur, 56000, Malaysia
National University of Malaysia
Cheras, Kuala Lumpur, 56000, Malaysia
Related Publications (1)
Berohan ND, Alias H, Ishak S, Mohammed Nawi A, Azman N, Sohaimi D, Kamisan Atan I, Abd Wahab N, Kalok AH, Mohamad AS, Abd Rahman R. 4 vs 7 points self-monitoring blood glucose in gestational diabetes mellitus on diet modification: randomised clinical trial in a single tertiary centre in Malaysia. Arch Gynecol Obstet. 2024 Oct;310(4):1959-1965. doi: 10.1007/s00404-024-07661-5. Epub 2024 Aug 7.
PMID: 39110209DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Noor Dalila Berohan
National University of Malaysia
- STUDY DIRECTOR
Norasyikin Abd Wahab
National University of Malaysia
- STUDY CHAIR
Shuhaila Ahmad
National University of Malaysia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 17, 2019
First Posted
September 24, 2019
Study Start
October 25, 2019
Primary Completion
June 30, 2022
Study Completion
June 30, 2022
Last Updated
November 9, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share
The IPD will only be shared upon request. The data that can be shared will be the blood glucose levels and pregnancy outcomes.